期刊
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 18
卷 18, 期 -, 页码 181-205出版社
ANNUAL REVIEWS
DOI: 10.1146/annurev-bioeng-110315-020137
关键词
tolerance; immunomodulation; cell therapies; nanotechnology; inverse vaccines
资金
- NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009910, R01EB013198] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026543] Funding Source: NIH RePORTER
- NIBIB NIH HHS [R01 EB013198, R01 EB009910] Funding Source: Medline
- NIDDK NIH HHS [P30 DK020572] Funding Source: Medline
- NINDS NIH HHS [R01 NS026543] Funding Source: Medline
The undesired destruction of healthy cells, either endogenous or transplanted, by the immune system results in the loss of tissue function or limits strategies to restore tissue function. Current therapies typically involve non-specific immunosuppression that may prevent the appropriate response to an antigen, thereby decreasing humoral immunity and increasing the risks of patient susceptibility to opportunistic infections, viral reactivation, and neoplasia. The induction of antigen-specific immunological tolerance to block undesired immune responses to self-or allogeneic antigens, while maintaining the integrity of the remaining immune system, has the potential to transform the current treatment of autoimmune disease and serve as a key enabling technology for therapies based on cell transplantation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据